FULC
Fulcrum Therapeutics, Inc.
$3.77
+0.05 (+1.34%)
At close · Jul 7
Market Cap
$251.21M
Shares
66,633,321
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | Filing Date | Period | Open |
|---|---|---|---|
| 8-K | 2026-06-25 | 2026-06-24 | |
| 8-K | 2026-06-11 | 2026-06-05 | |
| 8-K | 2026-06-04 | 2026-05-31 | |
| 8-K | 2026-06-01 | — | |
| DEF 14A | 2026-04-30 | 2026-06-24 | |
| 10-Q | 2026-04-27 | 2026-03-31 | |
| 8-K | 2026-04-27 | 2026-04-23 | |
| 8-K | 2026-02-24 | — | |
| 10-K | 2026-02-24 | 2025-12-31 | |
| 8-K | 2026-01-12 | — | |
| 8-K | 2025-12-11 | 2025-12-10 | |
| 8-K | 2025-12-08 | — | |
| 8-K | 2025-10-29 | — | |
| 10-Q | 2025-10-29 | 2025-09-30 | |
| 8-K | 2025-08-28 | — | |
| 10-Q | 2025-07-29 | 2025-06-30 | |
| 8-K | 2025-07-29 | — | |
| 8-K | 2025-06-27 | 2025-06-26 | |
| 8-K | 2025-05-01 | — | |
| 10-Q | 2025-05-01 | 2025-03-31 | |
| DEF 14A | 2025-04-30 | 2025-04-25 | |
| 8-K | 2025-03-04 | 2025-02-26 | |
| 10-K | 2025-02-25 | 2024-12-31 | |
| 8-K | 2025-02-25 | — | |
| 8-K | 2025-01-13 | — | |
| 8-K | 2024-12-23 | 2024-12-18 | |
| 8-K | 2024-11-13 | — | |
| 10-Q | 2024-11-13 | 2024-09-30 | |
| 8-K | 2024-11-12 | — | |
| 8-K | 2024-09-24 | — | |
| 8-K | 2024-09-12 | — | |
| 8-K | 2024-08-22 | 2024-08-21 | |
| 8-K | 2024-07-31 | — | |
| 10-Q | 2024-07-31 | 2024-06-30 | |
| 8-K | 2024-06-17 | — | |
| 8-K | 2024-05-13 | 2024-05-11 | |
| 10-Q | 2024-05-13 | 2024-03-31 | |
| DEF 14A | 2024-04-19 | 2024-06-17 | |
| 10-K | 2024-02-27 | 2023-12-31 | |
| 8-K | 2024-02-27 | — | |
| 8-K | 2023-11-07 | — | |
| 10-Q | 2023-11-07 | 2023-09-30 | |
| 8-K | 2023-10-02 | 2023-09-28 | |
| 8-K | 2023-08-22 | — | |
| 8-K | 2023-08-03 | 2023-08-02 | |
| 10-Q | 2023-08-03 | 2023-06-30 | |
| 8-K | 2023-07-10 | 2023-07-05 | |
| 10-K/A | 2023-06-26 | 2021-12-31 | |
| 10-K/A | 2023-06-26 | 2022-12-31 | |
| 10-K/A | 2023-06-23 | 2020-12-31 |
Showing 1–50 of 113 filings